prazosin has been researched along with Hepatitis in 1 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
Hepatitis: INFLAMMATION of the LIVER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kondratenko, TIa | 1 |
| Kuzina, NV | 1 |
| Zakharova, IV | 1 |
| Leont'ev, AF | 1 |
| Pashkevich, DD | 1 |
| Seniakovich, VM | 1 |
| Aleksandrov, AE | 1 |
| Klochkov, SA | 1 |
1 trial available for prazosin and Hepatitis
| Article | Year |
|---|---|
[Adrenergic receptors in the liver parenchyma in children with chronic hepatitis].
Topics: Adolescent; Binding Sites; Child; Child, Preschool; Chronic Disease; Dihydroalprenolol; Hepatitis; H | 1992 |